It is administered by subcutaneous injection once a week
A new, large-scale study published in the journal Nature Medicine reported that Ozempic and similar medications for weight loss may lower risk of dozens of health conditions, including Alzheimers disease, substance use disorders, and mental health conditions
Shastry, M., Jacob, S., Rugo, H
Originally developed for the treatment of type 2 diabetes mellitus, these agentsincluding semaglutide and tirzepatidehave demonstrated substantial efficacy in promoting weight loss and are increasingly reshaping therapeutic strategies for obesity, cardiovascular and kidney disease, and potentially substance use disorders.[1,2] Historically, paradigm-shifting therapeutics have periodically redefined clinical practice
Medved I, Brown MJ, Bjorksten AR: N-acetylcysteine enhances muscle cysteine and glutathione availability and attenuates fatigue during prolonged exercise in endurance-trained individuals